Business Description

VLPs are multi-protein structures, which mimic the organization and conformation of authentic native viruses, but lack the viral genome, and may produce safer and cheaper vaccine candidates. Due to their highly repetitive surfaces, VLPs are able to induce strong B cell responses without adjuvants by effectively crosslinking specific receptors on B cells. Studies have shown that VLP vaccines can stimulate humoral and cellular immune responses, thus providing effective antiviral protection. (Website: https://sars-cov-2.creative-biolabs.com/virus-like-particles-based-vaccine-development-services-for-sars-cov2.htm)

• Reviews & Ratings
• Write a Review